Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCreo Medical Regulatory News (CREO)

Share Price Information for Creo Medical (CREO)

Share Price is delayed by 15 minutes
Get Live Data
13.50    0.00 (0.00%)
Bid:
13.25
Ask:
13.75
Spread: 0.50 (3.774%)
Market Cap: £65.58m
CREO Live PriceLast checked at - London Stock Exchange

Intraday Creo Medical Share Chart

Shareholder notification

26 Mar 2010 16:35

RNS Number : 2905J
China Real Estate Opportunities PLC
26 March 2010
 



China Real Estate Opportunities plc

 

Significant shareholder notification

 

In accordance with Rule 17 of the AIM Rules, China Real Estate Opportunities plc ("CREO" or the "Company") announces that on 26 March 2010 it was notified by a director and a significant shareholder of the following change in one of its significant shareholders.

 

On 22 March 2010, Treasury Holdings transferred its interests in Daylasin Limited to Richard Barrett, a director of the Company, and John Ronan, a significant shareholder in the Company. Mr Barrett and Mr. Ronan each hold 50 per cent of the shares in Treasury Holdings and, following this transaction, Daylasin Limited respectively.

 

Daylasin holds 5,345,819 ordinary shares of no par value in the Company, representing 11.13 per cent of the issued share capital of the Company. The price paid by Mr. Barrett and Mr. Ronan for their interests in Daylasin Limited equates to 348p for each share in the Company held by Daylasin Limited.

 

Following this transaction, Richard Barrett remains interested in 8,955,518 ordinary no par value shares representing 18.64 per cent of the issued share capital of the Company, John Ronan remains interested in 11,610,008 ordinary no par value shares representing 24.17 per cent of the issued share capital of the Company, and Treasury Holdings has no further interests in the Company.

 

Contact:

CREO

Ray Horney, Chairman

Tel: +44 (0) 1273 775 225

 

Sarah Moriarty, Investor Relations

Tel: + 353 1 618 9455

 

Matrix Corporate Capital LLP

Paul Fincham, Rob Naylor

Tel: +44 (0) 20 3206 7000

 

Davy

Des Carville

Tel: +353 1 679 6363

 

Citigate Dewe Rogerson Limited

Tom Baldock

Tel: +44 (0) 20 7638 9571

 

Murray Consultants

Ed Micheau

Tel: +353 1 498 0300

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKKADNABKDNNB
Date   Source Headline
14th Dec 20069:17 amRNSProposed Acquisition
8th Dec 200610:00 amRNSSuspension of Shares
8th Dec 200610:00 amRNSSuspension- China Real Estate
27th Sep 20069:30 amRNSInterim Results
25th Sep 200611:21 amRNSRe: Grant of share options
4th Jan 200611:02 amRNSStmnt re Share Price Movement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.